Showing results (31-40 of 127) with videos related to
Sort By:
Pageof 13
Reumatologia Clinica|July 29, 2011
[Treatment of lupus nephritis]Lucía Silva Fernández, José Luis Andréu Sánchez, Ellen M GinzlerRevista Clinica Espanola|February 16, 2008
Current therapy of lupus nephritis. Which is the best option?L Silva-Fernández, J L Andreu-Sánchez, E M GinzlerLupus|February 1, 1996
Heart rate variability in patients with systemic lupus erythematosusK S Stein, I C McFarlane, N Goldberg, et al.Journal of the American Geriatrics Society|February 1, 1979
Systemic lupus erythematosus in the older age group: computer analysisJ Dimant, E M Ginzler, M Schlesinger, et al.The Journal of Rheumatology|October 1, 1993
Hypertension increases the risk of renal deterioration in systemic lupus erythematosusE M Ginzler, D T Felson, J M Anthony, et al.Arthritis and Rheumatism|December 30, 2009
Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trialEllen M Ginzler, David Wofsy, David Isenberg, et al.Life Science Alliance|October 13, 2022
Autoimmune RNA dysregulation and seizures: therapeutic prospects in neuropsychiatric lupusIlham A Muslimov, Valerio Berardi, Stacy Stephenson, et al.Arthritis Research & Therapy|February 14, 2012
Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trialEllen M Ginzler, Stephen Wax, Anand Rajeswaran, et al.Kidney International|November 6, 2009
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritisJai Radhakrishnan, Dimitrios-Anestis Moutzouris, Ellen M Ginzler, et al.Lupus|May 26, 2016
The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trialsB H Rovin, M A Dooley, J Radhakrishnan, et al.Pageof 13